Booth Robert F.
SEC insider (Form 3/4/5 filer). CIK 0001507567. Director at Summit Therapeutics Inc. (SMMT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in MIAMI, FL.
Companies Booth Robert F. has filed insider reports for
- Summit Therapeutics Inc. (SMMT): Director
Booth Robert F.
CIK: 0001507567
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Summit Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
7.2K shares at avg. $8.76- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
6.9K shares at avg. $9.18-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 7,180 | $8.76 | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 6,855 | $9.18 | - | Direct |
1-4 of 4 transactions